DE60015042D1 - Nukleotidsequenzen, welche für das dapF-Gen kodieren - Google Patents

Nukleotidsequenzen, welche für das dapF-Gen kodieren

Info

Publication number
DE60015042D1
DE60015042D1 DE60015042T DE60015042T DE60015042D1 DE 60015042 D1 DE60015042 D1 DE 60015042D1 DE 60015042 T DE60015042 T DE 60015042T DE 60015042 T DE60015042 T DE 60015042T DE 60015042 D1 DE60015042 D1 DE 60015042D1
Authority
DE
Germany
Prior art keywords
polynucleotide
dapf
polypeptide
codes
extent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60015042T
Other languages
English (en)
Other versions
DE60015042T3 (de
DE60015042T2 (de
Inventor
Oliver Kirchner
Dr Bathe
Dr Moeckel
Michael Hartmann
Dr Kalinowski
Prof Puehler
Dr Pfefferle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Evonik Operations GmbH
Original Assignee
Degussa GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7921689&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60015042(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Degussa GmbH filed Critical Degussa GmbH
Application granted granted Critical
Publication of DE60015042D1 publication Critical patent/DE60015042D1/de
Publication of DE60015042T2 publication Critical patent/DE60015042T2/de
Publication of DE60015042T3 publication Critical patent/DE60015042T3/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/77—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Corynebacterium; for Brevibacterium
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/90—Isomerases (5.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00—Preparation of nitrogen-containing organic compounds
    • C12P13/04—Alpha- or beta- amino acids
    • C12P13/08—Lysine; Diaminopimelic acid; Threonine; Valine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/15—Corynebacterium

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DE60015042T 1999-09-11 2000-07-25 Nukleotidsequenzen, welche für das dapF-Gen kodieren Expired - Lifetime DE60015042T3 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19943587A DE19943587A1 (de) 1999-09-11 1999-09-11 Neue für das dapF-Gen codierende Nukleotidsequenzen
DE19943587 1999-09-11

Publications (3)

Publication Number Publication Date
DE60015042D1 true DE60015042D1 (de) 2004-11-25
DE60015042T2 DE60015042T2 (de) 2006-02-09
DE60015042T3 DE60015042T3 (de) 2008-03-06

Family

ID=7921689

Family Applications (2)

Application Number Title Priority Date Filing Date
DE19943587A Withdrawn DE19943587A1 (de) 1999-09-11 1999-09-11 Neue für das dapF-Gen codierende Nukleotidsequenzen
DE60015042T Expired - Lifetime DE60015042T3 (de) 1999-09-11 2000-07-25 Nukleotidsequenzen, welche für das dapF-Gen kodieren

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE19943587A Withdrawn DE19943587A1 (de) 1999-09-11 1999-09-11 Neue für das dapF-Gen codierende Nukleotidsequenzen

Country Status (17)

Country Link
US (1) US6670156B1 (de)
EP (1) EP1085094B2 (de)
JP (1) JP2001095593A (de)
KR (1) KR20010050423A (de)
CN (1) CN100387714C (de)
AT (1) ATE280232T1 (de)
AU (1) AU5507400A (de)
BR (1) BR0004059A (de)
CA (1) CA2317058A1 (de)
DE (2) DE19943587A1 (de)
DK (1) DK1085094T3 (de)
ES (1) ES2231089T5 (de)
HU (1) HUP0003553A2 (de)
ID (1) ID27239A (de)
MX (1) MXPA00008678A (de)
SK (1) SK13282000A3 (de)
ZA (1) ZA200004723B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4075087B2 (ja) 1996-12-05 2008-04-16 味の素株式会社 Ｌ−リジンの製造法
US20040096095A1 (en) * 2002-07-18 2004-05-20 August Technology Corp. Inspection tool with partial framing/windowing camera
US20040109600A1 (en) * 2002-07-18 2004-06-10 Cory Watkins Inspection tool with partial framing camrea
CN101006051B (zh) 2004-06-10 2014-09-10 密歇根州州立大学托管理事会 由赖氨酸合成己内酰胺
CN101541746B (zh) * 2007-02-20 2013-01-02 密执安州立大学董事会 用于生产己内酰胺的催化脱氨基
WO2010011967A1 (en) * 2008-07-24 2010-01-28 Draths Corporation Methods of making cyclic amide monomers, and related derivatives and methods
EP2479279A1 (de) 2011-01-20 2012-07-25 Evonik Degussa GmbH Verfahren zur fermentativen Herstellung schwefelhaltiger Aminosäuren
KR102270626B1 (ko) 2013-08-30 2021-06-30 에보니크 오퍼레이션즈 게엠베하 메티오닌 신타제 활성 및 메티오닌 유출이 개선된 메티오닌 생산용 미생물
US10400257B2 (en) 2014-10-09 2019-09-03 Cathay R&D Center Co., Ltd Expression of recombinant tetracycline efflux pumps for the production of lysine or lysine-derived products, and methods and applications thereof
EP3467099A1 (de) 2017-10-05 2019-04-10 Evonik Degussa GmbH Verfahren zur fermentativen herstellung von l-aminosäuren
RU2019128538A (ru) 2018-09-26 2021-03-11 Эвоник Оперейшенс ГмбХ Способ ферментативного получения l-лизина
WO2023222510A1 (en) 2022-05-18 2023-11-23 Evonik Operations Gmbh Biotechnological production of desferrioxamines and analogs thereof
WO2023222505A1 (en) 2022-05-18 2023-11-23 Evonik Operations Gmbh Biotechnological production of monomers of bisucaberins, desferrioxamines and analogs thereof
WO2023222515A1 (en) 2022-05-18 2023-11-23 Evonik Operations Gmbh Biotechnological production of bisucaberins, desferrioxamines and analogs thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56160997A (en) 1980-05-16 1981-12-11 Ajinomoto Co Inc Preparation of l-lysine by fermenaition method
JPH0655149B2 (ja) 1985-03-12 1994-07-27 協和醗酵工業株式会社 Ｌ―リジンの製造法
JPH07155184A (ja) * 1993-12-08 1995-06-20 Ajinomoto Co Inc 発酵法によるｌ−リジンの製造法
SK285201B6 (sk) 1996-12-05 2006-08-03 Ajinomoto Co., Inc. Rekombinantná DNA, autonómne reprodukovaná v bunkách koryneformnej baktérie, koryneformná baktéria a spôsob výroby L-lyzínu, vektor pVK7
JP2003135066A (ja) * 1999-03-19 2003-05-13 Ajinomoto Co Inc Ｌ−リジンの製造法
US20030049804A1 (en) 1999-06-25 2003-03-13 Markus Pompejus Corynebacterium glutamicum genes encoding metabolic pathway proteins
EP1257649B1 (de) 1999-06-25 2010-01-20 Paik Kwang Industrial Co., Ltd. Gene von corynebacterium glutamicum kodierend für stoffwechselproteine
JP4623825B2 (ja) 1999-12-16 2011-02-02 協和発酵バイオ株式会社 新規ポリヌクレオチド

Also Published As

Publication number Publication date
EP1085094B2 (de) 2007-11-07
DK1085094T3 (da) 2005-02-21
HU0003553D0 (en) 2000-09-08
ES2231089T3 (es) 2005-05-16
CN100387714C (zh) 2008-05-14
HUP0003553A2 (hu) 2003-03-28
KR20010050423A (ko) 2001-06-15
AU5507400A (en) 2001-03-15
DE60015042T3 (de) 2008-03-06
BR0004059A (pt) 2001-10-02
ATE280232T1 (de) 2004-11-15
SK13282000A3 (sk) 2002-02-05
ID27239A (id) 2001-03-15
DE19943587A1 (de) 2001-03-15
ZA200004723B (en) 2001-03-13
CN1288055A (zh) 2001-03-21
ES2231089T5 (es) 2008-05-01
CA2317058A1 (en) 2001-03-11
DE60015042T2 (de) 2006-02-09
MXPA00008678A (es) 2002-05-23
JP2001095593A (ja) 2001-04-10
EP1085094A2 (de) 2001-03-21
EP1085094A3 (de) 2003-01-15
US6670156B1 (en) 2003-12-30
EP1085094B1 (de) 2004-10-20

Similar Documents

Publication Publication Date Title
DE60015042D1 (de) Nukleotidsequenzen, welche für das dapF-Gen kodieren
HU0003651D0 (en) Novel nucleotide sequences coding for the pgi gene
WO2002020542A3 (en) Nucleotide sequences which code for the gap2 gene
WO2002010209A8 (en) Nucleotide sequences which code for the meth gene
WO2002002778A8 (en) Nucleotide sequences which code for the mdha gene from corynebacterium glutamicum
AU2001273977A1 (en) Novel nucleotide sequences coding for the glbo gene
AU2001279663A1 (en) Nucleotide sequences which code for the lysr2 gene
WO2002022666A3 (en) Nucleotide sequences which code for the gora gene
EP1217069A3 (de) Für das ilvE-Gen kodierende Nukleotidsequenzen
WO2002022829A3 (en) Nucleotide sequences which code for the ppsa gene
WO2002010206A3 (en) Nucleotide sequences which code for the metf gene
WO2002024737A8 (en) Nucleotide sequences which code for the dps gene of c. glutamicum
WO2002022814A3 (en) Nucleotide sequences which code for the atr43 gene
WO2002022633A3 (en) Nucleotide sequences which code for the atr61 gene
WO2002026755A3 (en) Nucleotide sequences which code for the ppgk gene
WO2002018427A3 (en) Nucleotide sequences which code for the cita gene
WO2002024716A3 (en) Nucleotide sequences which code for the tmk gene
WO2002022843A3 (en) Nucleotide sequences which code for the dep34 gene
WO2002020799A3 (en) Nucleotide sequences which code for the luxs gene
WO2002020573A3 (en) Nucleotide sequences which code for the gpmb gene
WO2001085948A3 (en) Nucleotide sequences which code for the coryneform acyl carrier protein gene
WO2002018589A3 (en) Nucleotide sequence coding for the sigc gene of corynebacterium glutamicum
WO2002020572A3 (en) Nucleotide sequences coding for the chrs gene
HUP0004783A2 (hu) Új, a glk-gént kódoló nukleotid szekvenciák
AU2001279755A1 (en) Nucleotide sequences which code for the sahh gene

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: DEGUSSA GMBH, 40474 DUESSELDORF, DE

8327 Change in the person/name/address of the patent owner

Owner name: EVONIK DEGUSSA GMBH, 40474 DUESSELDORF, DE

8363 Opposition against the patent
8366 Restricted maintained after opposition proceedings